Chris Wood

Chris Wood
AI
The paradox of AI in lung nodules
In this column, RevealDx CEO Chris Wood describes a pathway to reducing lung cancer mortality that isn't being fully utilized in the U.S.
November 24, 2025
Chris Wood, CEO of RevealDx
Page 1 of 1
Top Stories
Football Players Scrimmage
MRI
Adding AI to MRI improves return to play classification frameworks
Predicting when athletes can safely return to play after an injury is key.
Runner Street Thumbnail Adobe Augustas Cetkauskas
Ultrasound
Marathon training does not have long-term negative effects on heart
Scans in a 73-year-old man with biochemically recurrent prostate cancer (prostate-specific antigen level of 0.5 ng/mL) who underwent PET/CT with 9.4 mCi of F-18 piflufolastat and a second PET/CT examination with 8.1 mCi of copper 61-NODAGA (1,4,7-triazacyclononane,1-glutaric acid-4,7-acetic acid)–prostate-specific membrane antigen for imaging and therapy (Cu-61 PSMA I&T) 24 days apart, with no intervening therapy. Maximum intensity projection (MIP) images obtained (A) 1 hour after F-18 piflufolastat administration and (B) 1, (C) 2, and (D) 4 hours after Cu-61 PSMA I&T administration are shown. Physiologic uptake is seen in the lacrimal glands, salivary glands, liver, spleen, kidneys, ureters, and bladder. Pathologic uptake in pelvic nodal metastases is labeled with arrows. The F-18 piflufolastat PET/CT MIP image reveals two avid pelvic nodal metastases (arrows). Cu-61 PSMA I&T PET/CT scans demonstrate three avid pelvic nodal metastases on 1-hour and 2-hour images (arrows); five avid pelvic nodal metastases were suspected on the 4-hour image (arrows).
Molecular Imaging
Phase I trial reveals the potential of a new PSMA-PET tracer
Images depict a 50-year-old woman with a lesion detected during screening ultrasound. (A) Transverse and (B) longitudinal images reveal a 0.5-cm hypoechoic lesion (arrow) in the left breast. (C) Transverse color Doppler ultrasound image does not show an increase in vascularity. Two readers classified the lesion as a mass, whereas two others categorized it as a nonmass lesion, leading to its designation as a controversial nonmass lesion. Ultrasound-guided core needle biopsy and subsequent pathologic examination confirmed a nonproliferative breast change.
Womens Imaging
Radiologists can designate nonmass lesions on breast ultrasound
Coronavirus
MRI
Long COVID's neurological effects persist
More in Authors
Erik Jacobsson
November 18, 2025
Erik Jacobsson
Erez Meltzer
November 18, 2025
Giuseppe Scappatura
September 10, 2025
Giuseppe Scappatura
John Memarian
August 18, 2025
John Memarian
Angela Adams
August 5, 2025
1697891335052
Jordan Bazinsky
June 12, 2025
Jordan Bazinsky New Headshot (final)
Sanjeev Bhalla, MD, and Mensur Koso, MD
May 8, 2025
Deborah Barnes
June 7, 2024
Erik L. Ridley
October 4, 2010
Erik Ridley
Page 1 of 1